Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 132 participants.
Also called NCT07089576
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 132 participants
- Registry
-
NCT07089576
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Germany, Italy
- Registry status
- Recruiting
Technical summary
Registry record NCT07089576. Non-randomized; no masking; primary purpose treatment. Start 2025-11-04 (actual); primary completion 2028-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
- Acronym
- ARTIZEN
- Condition
- Aortic Arch Aneurysm
- Condition
- Aortic Arch Dissection
- Condition
- Chronic Aortic Dissection
- Condition
- Acute Aortic Dissection
- Intervention (Device)
- Arcevo™ LSA Hybrid Stent Graft System
- Lead sponsor
- Artivion Inc.
- Collaborator
- Bright Research Partners
Record details
- Record id
cardio:ct-nct07089576- Content hash
d40c93538142e8815cdb280d08f2de143b5ebda059dd86aa7bd15eb80312b3a7